Next Article in Journal
Transient Ischemic Attacks as the First Presentation of JAK2-V617F Positive Chronic Myeloproliferative Neoplasm
Previous Article in Journal
Genotype-Phenotype Correlation of β-Thalassemia Spectrum of Mutations in an Indian Population
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Hematology Reports
Volume 4
Issue 2
10.4081/hr.2012.e13
hematolrep-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Hematology Reports is published by MDPI from Volume 14 Issue 1 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with PAGEPress.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Thrombotic Microangiopathy Associated with Bortezomib Treatment in a Patient with Relapsed Multiple Myeloma

by
Urpu Salmenniemi
* and
Kari Remes
Department of Medicine, Turku University Hospital, 20521 Turku, Finland
*
Author to whom correspondence should be addressed.
Hematol. Rep. 2012, 4(2), e13; https://doi.org/10.4081/hr.2012.e13
Submission received: 29 November 2011 / Revised: 21 April 2012 / Accepted: 12 June 2012 / Published: 29 June 2012

Abstract

Thrombotic thrombocytopenic purpura (TTP) and hemolytic-uremic syndrome (HUS) describe microvascular occlusive disorders characterized by thrombocytopenia due to increased platelet aggregation and fragmentation hemolysis. We report here what to our knowledge is the second case of TTP/HUS associated with bortezomib treatment.
Keywords: thrombotic thrombocytopenic purpura; hemolytic-uremic syndrome; multiple myeloma thrombotic thrombocytopenic purpura; hemolytic-uremic syndrome; multiple myeloma

Share and Cite

MDPI and ACS Style

Salmenniemi, U.; Remes, K. Thrombotic Microangiopathy Associated with Bortezomib Treatment in a Patient with Relapsed Multiple Myeloma. Hematol. Rep. 2012, 4, e13. https://doi.org/10.4081/hr.2012.e13

AMA Style

Salmenniemi U, Remes K. Thrombotic Microangiopathy Associated with Bortezomib Treatment in a Patient with Relapsed Multiple Myeloma. Hematology Reports. 2012; 4(2):e13. https://doi.org/10.4081/hr.2012.e13

Chicago/Turabian Style

Salmenniemi, Urpu, and Kari Remes. 2012. "Thrombotic Microangiopathy Associated with Bortezomib Treatment in a Patient with Relapsed Multiple Myeloma" Hematology Reports 4, no. 2: e13. https://doi.org/10.4081/hr.2012.e13

APA Style

Salmenniemi, U., & Remes, K. (2012). Thrombotic Microangiopathy Associated with Bortezomib Treatment in a Patient with Relapsed Multiple Myeloma. Hematology Reports, 4(2), e13. https://doi.org/10.4081/hr.2012.e13

Article Metrics

Back to TopTop